• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Biolase

Medtech stories we missed this week: March 2, 2018

March 2, 2018 By Danielle Kirsh

missedmedtech-0302

From InspireMD’s new distribution deals to Kelynium’s distribution deal with a mystery partner, here are medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks distribution deals in Greece, Caribbean InspireMD announced in a March 1 press release that it has signed exclusive distribution agreements with T-Vascular IKE Medical Supplies in […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance Tagged With: Biolase, Dexalytic, Getinge, Hologic Diagnostics, icad, InspireMD, kelyniam, medtech, meridianpm, s-ray

Medtech stories we missed: Feb. 10, 2017

February 10, 2017 By Danielle Kirsh

From Glytec partnering to beat diabetes to Biolase, Gramercy Extremity Orthopedics and more getting FDA clearances, here are 7 recent medtech stories we missed this week, but were still worth mentioning. 1. BioTime proposes public offering of common stock Clinical-stage biotechnology company BioTech is intending to offer common stock shares in an underwritten public offering. BioTime focuses […]

Filed Under: Business/Financial News, Diabetes, Food & Drug Administration (FDA) Tagged With: Biolase, BioTime, Geneva health Solutions, Glytec, Gramercy Extremity Orthopedics, Lombard, Nioness

Medtech stories we missed: Feb. 3, 2017

February 3, 2017 By Chris Newmarker

flashlight MassDevice stories missed

From disappointing Getinge earnings to a $2.25 billion U.S. Defense Department contract for Cardinal Health to a host of 510(k) clearances, here are seven recent medtech stories that are still worth a mention. 1. Getinge disappoints on earnings—again Getinge stock took a nearly 10% tumble last week after releasing earnings that Reuters says lagged analyst […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), mHealth (Mobile Health) Tagged With: Biogen, Biolase, Bioverativ, Cambridge Cognition Holdings, Cardinal Health, Getinge, medtech, Precision Spine, U.S. Department of Defese, Zimmer Biomet

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS